Your Article Summary
ViiV Healthcare launches: A new specialist HIV company dedicated to delivering advances in HIV treatment and care
GlaxoSmithKline, 11/04/09
ViiV Healthcare, a new specialist HIV company established by GlaxoSmithKline (GSK) and Pfizer, was officially launched. Dr Dominique Limet, the Chief Executive Officer of ViiV Healthcare, outlined the company’s ethos and priorities to tackle the increasingly diverse and complex needs of people living with HIV/AIDS worldwide.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09
U.S. Food and Drug Administration Approves ABILIFY for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients
Bristol Myers-Squibb Company, 11/24/09
AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
Bayer MaterialScience invests in high-tech products for medical technology
BayNews International, 11/24/09
Baytubes carbon nanotubes in marine coatings help reduce frictional resistance
BayNews International, 11/24/09
New Makrofol ID film system developed - Watermarks for polycarbonate cards
BayNews International, 11/24/09
Article Search
Sponsor


See Latest Articles


